Cost-Effectiveness of the Implantable HeartMate II Left Ventricular Assist Device for Patients Awaiting Heart Transplantation
Although HeartMate II LVAD implantation significantly increases survival compared with conventional medical management, it does not provide good value for the money spent according to established thresholds of cost-effectiveness in the UK.
1 min read
